Arteris (AIP) Cash & Equivalents (2020 - 2026)

Arteris (AIP) has 7 years of Cash & Equivalents data on file, last reported at $11.7 million in Q1 2026.

• Quarterly Cash & Equivalents fell 28.69% year-over-year to $11.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.7 million (down 28.69% YoY) and the FY2025 annual result came in at $33.9 million, up 147.74% from the prior year.
• Cash & Equivalents declined to $11.7 million in Q1 2026, from $33.9 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $82.2 million in Q1 2022 to a low of $11.7 million in Q1 2026.
• A 5-year average of $31.3 million and a median of $22.1 million in 2024 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents surged 506.71% — and 2023, when it plunged 72.69%.
• Tracing AIP's Cash & Equivalents over 5 years: stood at $37.4 million in 2022, then tumbled by 63.4% to $13.7 million in 2023, then slipped by 0.09% to $13.7 million in 2024, then soared by 147.74% to $33.9 million in 2025, then tumbled by 65.56% to $11.7 million in 2026.
• The last three Cash & Equivalents figures came in at $11.7 million (Q1 2026), $33.9 million (Q4 2025), and $17.4 million (Q3 2025), per Business Quant data.